CLINICAL_TRIALS
trial_result
· 2021-06-30
Clinical Trial Update: The Effect of Abobotulinum Toxin A on the Symptoms of Raynaud's Phenomenon [Phase 4]
Summary
Phase 4 trial investigating abobotulinum toxin A for Raynaud's Phenomenon; study terminated with posted results.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: University of Central Florida | Conditions: Raynaud Phenomenon | Phase 4 | Status: TERMINATED | Results posted: 2021-06-30